Update on emerging genetic tests currently available for clinical use in common cancers

Raman G, Avendano EE, Chen M
Record ID 32013000751
English
Authors' objectives: The main objective of this report is to provide succinct information on each identified genetic test through grey literature search since 2011. The contents in this report reflect the data of genetic tests that were obtained from manufacturers' Web sites or other commercial Web sites, and should not be considered as verified information or construed as definitive clinical evidence or as recommendations for their routine clinical use.
Authors' recommendations: Since 2011, a total of 66 new genetic tests available for clinical use in 10 common cancer conditions. This report of updating genetic tests for cancer conditions adds potentially important information on emerging tests that are in clinical use. The current report is a valuable source of genetic tests that are in clinical use with specific applicability to older adults. In addition, the yield from this report has helped us to generate topics for conducting systematic reviews of emerging genetic tests. Genetic testing is a rapidly evolving field with the potential to dramatically influence clinical decision-making. Health care providers, patients, payers, decision-makers, and consumers can benefit from staying abreast of newly-released tests.
Details
Project Status: Completed
Year Published: 2013
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Humans
  • Genetic Testing
  • Neoplasms
Contact
Organisation Name: Agency for Healthcare Research and Quality
Contact Address: Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name: martin.erlichman@ahrq.hhs.gov
Contact Email: martin.erlichman@ahrq.hhs.gov
Copyright: Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.